These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35777693)

  • 1. Randomized Trial of Surgical Left Atrial Appendage Closure: Protection Against Cerebrovascular Events.
    Madsen CV; Park-Hansen J; Holme SJV; Irmukhamedov A; Carranza CL; Greve AM; Al-Farra G; Riis RGC; Nilsson B; Clausen JSR; Nørskov AS; Kruuse C; Truelsen TC; Dominguez H
    Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):664-672. PubMed ID: 35777693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The left atrial appendage closure by surgery 2 trial: statistical analysis plan for a randomized multicenter trial exploring if the closure of the left atrial appendage during open-heart surgery reduces stroke irrespective of patients' stroke risk and preoperative atrial fibrillation status.
    Madsen CL; Park-Hansen J; Hadad R; Greve AM; Domínguez H
    Trials; 2024 May; 25(1):317. PubMed ID: 38741218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding left atrial appendage closure to open heart surgery provides protection from ischemic brain injury six years after surgery independently of atrial fibrillation history: the LAACS randomized study.
    Park-Hansen J; Holme SJV; Irmukhamedov A; Carranza CL; Greve AM; Al-Farra G; Riis RGC; Nilsson B; Clausen JSR; Nørskov AS; Kruuse CR; Rostrup E; Dominguez H
    J Cardiothorac Surg; 2018 May; 13(1):53. PubMed ID: 29792215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The left atrial appendage closure by surgery-2 (LAACS-2) trial protocol rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of preoperative atrial fibrillation status and stroke risk.
    Madsen CL; Park-Hansen J; Irmukhamedov A; Carranza CL; Rafiq S; Rodriguez-Lecoq R; Palmer-Camino N; Modrau IS; Hansson EC; Jeppsson A; Hadad R; Moya-Mitjans A; Greve AM; Christensen R; Carstensen HG; Høst NB; Dixen U; Torp-Pedersen C; Køber L; Gögenur I; Truelsen TC; Kruuse C; Sajadieh A; Domínguez H;
    Am Heart J; 2023 Oct; 264():133-142. PubMed ID: 37302738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
    López-Mínguez JR; Nogales-Asensio JM; Infante De Oliveira E; De Gama Ribeiro V; Ruiz-Salmerón R; Arzamendi-Aizpurua D; Costa M; Gutiérrez-García H; Fernández-Díaz JA; Martín-Yuste V; Rama-Merchán JC; Moreno-Gómez R; Benedicto-Buendía A; Íñiguez-Romo A
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):449-455. PubMed ID: 29754808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thoracoscopic Left Atrial Appendage Clipping: A Multicenter Cohort Analysis.
    van Laar C; Verberkmoes NJ; van Es HW; Lewalter T; Dunnington G; Stark S; Longoria J; Hofman FH; Pierce CM; Kotecha D; van Putte BP
    JACC Clin Electrophysiol; 2018 Jul; 4(7):893-901. PubMed ID: 30025689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of left atrial appendage surgical treatment on the incidence of ischemic cerebrovascular accidents in patients with atrial fibrillation undergoing cardiac surgery.
    Duan Y; Xu H; Li B; Yuan X; Sun H
    J Thorac Cardiovasc Surg; 2022 Oct; 164(4):1106-1116. PubMed ID: 33487413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery.
    Caliskan E; Sahin A; Yilmaz M; Seifert B; Hinzpeter R; Alkadhi H; Cox JL; Holubec T; Reser D; Falk V; Grünenfelder J; Genoni M; Maisano F; Salzberg SP; Emmert MY
    Europace; 2018 Jul; 20(7):e105-e114. PubMed ID: 29016813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage closure during mitral repair in patients without atrial fibrillation.
    Chikwe J; Roach A; Emerson D; Chen Q; Rowe G; Gill G; Peiris A; Ramzy D; Cheng W; Egorova N; Trento A
    J Thorac Cardiovasc Surg; 2024 Jul; 168(1):86-93.e5. PubMed ID: 37024010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion.
    Della Rocca DG; Magnocavallo M; Di Biase L; Mohanty S; Trivedi C; Tarantino N; Gianni C; Lavalle C; Van Niekerk CJ; Romero J; Briceño DF; Bassiouny M; Al-Ahmad A; Burkhardt JD; Natale VN; Gallinghouse GJ; Del Prete A; Forleo GB; Sanchez J; Lakkireddy D; Horton RP; Gibson DN; Natale A
    JACC Cardiovasc Interv; 2021 Nov; 14(21):2353-2364. PubMed ID: 34656496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial.
    Ailawadi G; Gerdisch MW; Harvey RL; Hooker RL; Damiano RJ; Salamon T; Mack MJ
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1002-9, 1009.e1. PubMed ID: 21906756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage closure device implantation in patients at very high risk for stroke.
    Hutt E; Wazni OM; Kaur S; Saliba WI; Tarakji KG; Kapadia S; Aguilera J; Barakat AF; Abdallah M; Jaber W; Rasmussen P; Hussain S; Uchino K; Wisco D; Lindsay BD; Kanj M; Hussein AA
    Heart Rhythm; 2020 Jan; 17(1):27-32. PubMed ID: 31302250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.